High Levels of SOX5 Decrease Proliferative Capacity of Human B Cells, but Permit Plasmablast Differentiation by Mirzokhid Rakhmanov (580449)

TIMP3 overexpression decreases tibial bone mechanical properties from macroscale to nanoscale mechanics. by Blandine Poulet (2939877)

“…<p>A, Von Kossa staining of tibia epiphysis and metaphysis of WT and TIMP3 Tg/Tg mice showed decreased trabecular bone in TIMP3 Tg/Tg mice (Magnification x2). …”

TMP decreased ROS generation in high glucose-treated endothelial cells. by Qiong Xu (204847)

Foskolin treatment to the fetal retina decreases corticogenesis. by Ciro Bonetti (147438)

“…(<b>b</b>) Quantification of cell cycle exit rate, (ratio between contra- and ipsi-lateral cortices), in E16.5 embryos upon administration of forskolin decreases corticogenesis rate (forskolin n = 5 DMSO n = 6 p = 0.00077, Student's t-test, two samples equal variants). …”

NO-np decreases subcutaneous abscess area in mice. by George Han (123334)

Decreased TNIP1 expression in SSc patients. by Yannick Allanore (58641)

“…(B) Consistent with these findings, a 1.7-fold decrease of <i>TNIP1</i> mRNA levels was observed in dermal fibroblasts from SSc patients (* indicates a <i>P</i>-value = 0.001 <i>vs.…”

Loss of either isoform of PLD decreases phagocytosis. by Wahida H. Ali (286470)

MES transiently decreases mitochondrial membrane potential. by Shingo Matsuyama (672132)

TMP decreased superoxide anions in high glucose-treated endothelial cells. by Qiong Xu (204847)

Decreased Th2 response in B7RP-1^+/− mice. by Bryan S. Clay (355764)

Ephrin-A2 and –A6 expression and EphA4 Tyr-602 phosphorylation decrease from nasal to temporal RGCs. by Ana Laura Ortalli (159899)

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

Subjects:

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

Subjects:

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

Subjects:

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

Subjects:

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

Subjects:

Hsp90 depletion decreases stress resistance. by Michelle D. Leach (108675)

Laquinimod prevents EAE and decreases encephalitogenicity of T cells. by Ulf Schulze-Topphoff (174453)

“…Representative FACS staining is shown including quantification (n = 4–5 mice per group). (E) Laquinimod decreases pathogenic potential of T cells. …”

The Intracellular level of FLASH decreases during apoptosis. by Song Chen (69646)

Dopamine decreases the refractive power in the lens periphery. by J. Marcus Schartau (365288)

“…Positive ΔBCD values indicate a decrease in refractive power <i>i.e.</i> an increase in BCD in the treated lens compared with the corresponding control lens from the same animal. …”